Neonatal cystic fibrosis screening
From DrKoop's partner site on breast cancer, MyBreastCancerNetwork.com
Cystic fibrosis screening - neonatal; Immunoreactive trypsinogen; IRT test What the risks are Risks associated with the test include:
Special considerations The IRT level does not indicate the severity of the CF. False-positives may occur.
Review Date: 05/16/2005 ![]() advertisement
| |||||||||||||||||
What's HOTGet our free newsletterPR Newswire |
|